| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |